Cited by 105Neuroinflammation and Neurodegeneration MechanismsImmune Response and InflammationInflammasome and immune disorders

CD 14 is a key organizer of microglial responses to CNS infection and injury

Janova, Hana, Böttcher, Chotima, Holtman, Inge R., Regen, Tommy, van Rossum, Denise, Götz, Alexander, Ernst, Anne‐Sophie, Fritsche, Christin +19 more·2016·Glia

Abstract

Microglia, innate immune cells of the CNS, sense infection and damage through overlapping receptor sets. Toll-like receptor (TLR) 4 recognizes bacterial lipopolysaccharide (LPS) and multiple injury-associated factors. We show that its co-receptor CD14 serves three non-redundant functions in microglia. First, it confers an up to 100-fold higher LPS sensitivity compared to peripheral macrophages to enable efficient proinflammatory cytokine induction. Second, CD14 prevents excessive responses to massive LPS challenges via an interferon β-mediated feedback. Third, CD14 is mandatory for microglial reactions to tissue damage-associated signals. In mice, these functions are essential for balanced CNS responses to bacterial infection, traumatic and ischemic injuries, since CD14 deficiency causes either hypo- or hyperinflammation, insufficient or exaggerated immune cell recruitment or worsened stroke outcomes. While CD14 orchestrates functions of TLR4 and related immune receptors, it is itself regulated by TLR and non-TLR systems to thereby fine-tune microglial damage-sensing capacity upon infectious and non-infectious CNS challenges.

Integrity signals

Registry

Crossref · 10.1002/glia.22955

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • RNA-seq data from postnatal primary microglia cell culture experiments showed that Tet2 expression was increased both at low and high levels of LPS treatment, as well as after treatment with fibronectin.

    “We further validated our observations by analyzing RNA sequencing (RNA-seq) data from postnatal primary microglia cell culture experiments (Janova et al., 2016), which showed that Tet2 expression was increased both at low and high levels of LPS treatment, as well as after treatment with fibronectin, which also promotes inflammation (Figure S1A).”

    From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Janova et al., 2016

  • The expression pattern in BV2 cells after LPS treatment is very similar to previously published RNA-seq data from LPS-treated primary microglia cells.

    “We first confirmed that the expression pattern in our BV2 cells after LPS treatment is very similar to previously published RNA-seq data from LPS-treated primary microglia cells in (Janova et al., 2016) (Figure S3A).”

    From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Janova et al., 2016

  • Tet2 expression is induced under inflammatory conditions mediated by different TLR agonists and fibronectin.

    “We and others (Janova et al., 2016), have observed that Tet2 expression is induced under inflammatory conditions mediated by different TLR agonists and fibronectin (Figure S1A-C).”

    From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Janova et al., 2016

The citation lists haven’t been fetched yet

References 38 · Cited by 105

Authors
Janova, H., Böttcher, C., Holtman, I. R., Regen, T., van Rossum, D., Götz, A., Ernst, A., Fritsche, C., Gertig, U., Saiepour, N., Gronke, K., Wrzos, C., Ribes, S., Rolfes, S., Weinstein, J., Ehrenreich, H., Pukrop, T., Kopatz, J., Stadelmann, C., Salinas‐Riester, G., Weber, M. S., Prinz, M., Brück, W., Eggen, B. J. L., Boddeke, H. W. G. M., Priller, J., & Hanisch, U.
Affiliations
  • Institute of Neuropathology, University of Göttingen Göttingen 37075 Germany
  • Charité – Universitätsmedizin Berlin (DE)
  • University Medical Center Groningen (NL)
  • Johannes Gutenberg University Mainz (DE)
  • University of Göttingen (DE)
  • University of Washington (US)
  • Max Planck Institute of Experimental Medicine (DE)
  • Universitätsmedizin Göttingen (DE)
  • University of Bonn (DE)
  • Transcriptome Analysis Laboratory University of Göttingen Göttingen 37077 Germany
  • University of Freiburg (DE)
Venue
Glia
Publisher
Wiley
Published
2015-12-18
Volume
64
Issue
4
Pages
635-649
ISSN
  • 0894-1491 (ISSN-L)
  • 1098-1136
OpenAlex
W2210133089
Cited by
105
References
38
Citations by year
2026: 5 · 2025: 6 · 2024: 16 · 2023: 9 · 2022: 24 · 2021: 7 · 2020: 9 · 2019: 9 · 2018: 4 · 2017: 13 · 2016: 3
FWCI
3.56
Type
journal article
Language
en
Open access
closed
Locations
  • Glia (publishedVersion)
  • PubMed (publishedVersion)
  • GRO (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Funders
National Institute of Neurological Disorders and Stroke (R01NS076620, K02NS065008)
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
CD14, microglia, TLR4, lipopolysaccharide, central nervous system infection, central nervous system injury, traumatic brain injury, ischemic stroke, interferon-beta, inflammatory cytokines, damage-associated molecular patterns, neuroinflammation, innate immunity, immune cell recruitment
MeSH terms
Animals, Brain, Brain Injuries, Cells, Cultured, Brain Ischemia, Disease Models, Animal, Escherichia coli, Escherichia coli Infections, Lipopolysaccharides, Macrophages, Male, Mice, Inbred C57BL, Neuroimmunomodulation, Interferon-beta, Microglia, Mice, Knockout, Lipopolysaccharide Receptors, Infarction, Middle Cerebral Artery, Stroke, Feedback, Physiological, Adaptor Proteins, Vesicular Transport, Toll-Like Receptor 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review